Avandia Heart Risk Litigation

Avandia (rosiglitazone) is a drug manufacture by GlaxoSmithKline used in the treatment of type 2 diabetes. The diabetes drug Avandia has been known to increase the risk of heart attack. To date, there have been 100,000 heart attacks recorded as being linked to the use of the diabetes drug Avandia. These occurrences of heart attacks resulting from Avandia use were documented by a scientist at the U.S. Food and Drug Administration (FDA).

The injurious effect Avandia has on cardiovascular health has put the FDA and the medical community on alert. Side effects and risks of taking the diabetes drug Avandia or any other drug containing rosiglitazone include the following:

  • Compromised cardiovascular health
  • Heart attack
  • Weight gain
  • Chest pain
  • Breathing troubles
  • Severely swollen hands and feet
  • Liver health problems
  • Visual impairment

Studies conducted on the health effects of Avandia use in type 2 diabetes patients also found the increased risk of suffering a bone fracture. This incidence of bone fractures, especially those occurring in the upper arms, was released in data collected by GlaxoSmithKline during their Avandia research. The manufacturer of Avandia also noted that bone fractures were more likely to occur in female patients.

Increased cardiovascular risks linked to Avandia usage:

  • +25% Increased Risk of Heart Failure
  • +43% Increased Risk of Heart Attack
  • +27% Increased Risk of Stroke

The following list describes common Avandia side effects. Please note that the list does not include all potential Avandia side effects:

  • Heart Attack (Myocardial Infarction)
  • Stroke (Cardiovascular Accident)
  • Congestive Heart Failure (Heart Failure)
  • Fluid Retention – Hypoglycemia
  • Cardiac Arrest
  • Hospitalization due to Cardiovascular problems
  • Exacerbation of pre-existing Heart conditions
  • Cardiac Death
  • Chest Pain
  • Death due to Heart Complications
  • Ischemic Heart Disease
  • Percutaneous Coronary Intervention
  • Coronary Angioplasy
  • Myocardial Ischemia
  • Arrythmia
  • Transient Ischemic Attack
  • Vetnricular Tachycardia – Fibrillation
  • Ventricular Asystole
  • Angiogram
  • Dyspnea – Edema
  • Hypertension – Fracture
  • Atrial Fibrillation
  • Coronary Clot Extraction
  • Acute Coronary Syndrome
  • Anigna Pectoris – Angina Unstable
  • Prinzmetal Angina
  • Coronary Artery Vasospasm
  • Arteriospasm Coronary
  • Coronary Artery Occlusion – Reocclusion
  • Coronary Artery Thrombosis – Disorder
  • Coronary Artery Disease or Syndrome
  • Coronary Bypass Thrombosis
  • Stenting – Artery Bypass Grafting
  • Other Related Injuries

 

Drug Information
Avandia (Rosiglitazone)
Manufacturer: GlaxoSmithKline
FDA Approval: May 25, 1999 for controlling blood sugar levels in type II diabetics
Generic Availability: N/A
Pregnancy Risk: Category C